A Randomized Clinical Trial of Secondary Prevention Among Women Hospitalized with Coronary Heart Disease

被引:13
作者
Mosca, Lori [1 ]
Christian, Allison H.
Mochari-Greenberger, Heidi
Kligfield, Paul [2 ]
Smith, Sidney C., Jr. [3 ]
机构
[1] Columbia Univ, Prevent Cardiol Program, New York Presbyterian Hosp, Med Ctr, New York, NY 10032 USA
[2] Cornell Univ, Weill Med Coll, New York, NY 10021 USA
[3] Univ N Carolina, Chapel Hill, NC USA
关键词
RISK-FACTOR MODIFICATION; LIPID-LOWERING-THERAPY; CASE-MANAGEMENT; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; ARTERY-DISEASE; UNITED-STATES; LIFE-STYLE; CHOLESTEROL; PROGRAM;
D O I
10.1089/jwh.2009.1481
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Secondary prevention improves survival, yet implementation is suboptimal. We tested the impact of a systematic hospital-based educational intervention vs. usual care to improve rates of adherence to secondary prevention guidelines among women hospitalized with coronary heart disease (CHD), according to their ethnic status. Methods: Women (n=304, 52% minorities) hospitalized with CHD were randomly assigned to a systematic secondary prevention educational intervention vs. usual care. Adherence to goals for smoking cessation, weight management, physical activity, blood pressure <140/90 mm Hg, low-density lipoprotein cholesterol (LDL-C) <100 mg/dL (2.59 mmol/L), and use of aspirin/anticoagulants, beta-blockers, and angiotensin-converting enzyme (ACE) inhibitors were assessed at 6 months. Results: On admission, minority women were less likely than white women to meet the goals for blood pressure (OR 0.46, 95% CI 0.26-0.80), LDL-C (OR 0.57, CI 0.33-0.94), and weight management (OR 0.40, 95% CI 0.20-0.82). There was no difference between the intervention and usual care groups in a summary score of goals met at study completion; however, minority women in the intervention group were 2.4 times more likely (95% CI 1.13-5.03) to reach the blood pressure goal at 6 months compared with minority women in usual care. White women in the intervention group were 2.86 times more likely (95% CI 1.06-7.68) to report use of beta-blockers at 6 months compared with white women in usual care. In a logistic regression model, the interaction term for ethnic status and group assignment was significant for achieving the blood pressure goal (p=0.009). Conclusions: A healthcare systems approach to educate women about secondary prevention and blood pressure control may differentially benefit ethnic minority women compared with white women.
引用
收藏
页码:195 / 202
页数:8
相关论文
共 34 条
  • [1] Nurse case management of hypercholesterolemia in patients with coronary heart disease: Results of a randomized clinical trial
    Allen, JK
    Blumenthal, RS
    Margolis, S
    Young, DR
    Miller, ER
    Kelly, K
    [J]. AMERICAN HEART JOURNAL, 2002, 144 (04) : 678 - 686
  • [2] Coronary risk factor modification in women after coronary artery bypass surgery
    Allen, JK
    [J]. NURSING RESEARCH, 1996, 45 (05) : 260 - 265
  • [3] *AM HEART ASS, 2003 HEART STROK STA
  • [4] American College of Sports Medicine, 1995, AM COLL SPORTS MED G, V5th
  • [5] BANDURA A, 1986, SOCIAL FDN THOUGHT A, P393
  • [6] Bandura A., 1991, Neurobiology of learning, emotion, and affect, VIV, P229, DOI DOI 10.4135/9781412952576.N182
  • [7] Task force #1 - Magnitude of the prevention problem: Opportunities and challenges
    Benjamin, EJ
    Smith, SC
    Cooper, RS
    Hill, MN
    Luepker, RV
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (04) : 588 - 603
  • [8] Usefulness of an acute coronary syndrome pathway to improve adherence to secondary prevention guidelines
    Biviano, AB
    Rabbani, LE
    Paultre, F
    Hurley, E
    Sullivan, J
    Giglio, J
    Mosca, L
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2003, 91 (10) : 1248 - 1250
  • [9] Influence of coronary nursing management follow up on lifestyle after acute myocardial infarction
    Carlsson, R
    Lindberg, G
    Westin, L
    Israelsson, B
    [J]. HEART, 1997, 77 (03) : 256 - 259
  • [10] COBBAERT C, 1994, EUR J CLIN CHEM CLIN, V32, P391